MarketPeel
Insider Trading Intelligence
DW

David B. Weiner

INO
DIRECTOR · INOVIO PHARMACEUTICALS, INC. · CIK 0001669080
FILING MIX · LIFETIME52%/48%
BUYS
47
SELLS
43
TOTAL VALUE
$920.9K
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
34,200
AVG SELL PX
$6.70
TRADE KIND
SHOWING 90 / 90
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David B. Weiner, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+53.33%-2.99%-0.43%-2.56%-4.11%
14d15+60.00%-5.06%-0.22%-4.84%-3.40%
30d15+80.00%-8.90%+3.02%-11.91%-15.60%
60d15+60.00%+0.96%+3.46%-2.50%-7.16%
90d15+66.67%+1.81%+7.71%-5.90%-10.16%
180d15+80.00%-14.93%+12.71%-27.64%-31.54%
1y15+86.67%-40.15%+21.21%-61.36%-68.78%
2y15+100.00%-75.10%+31.47%-106.58%-96.62%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
INO · 34,200 shares · as of May 20, 2026
0232,281464,562696,843929,124202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 47 buys / 43 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,20034,200May 20, 2026May 21, 2026View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
41,80041,800May 20, 2026May 21, 2026View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
9720Feb 26, 2026Feb 27, 2026View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
97287,592Feb 26, 2026Feb 27, 2026View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
2,1670May 21, 2025May 21, 2025View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
2,16786,620May 21, 2025May 21, 2025View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
97283,481Feb 26, 2025Feb 28, 2025View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
9720Feb 26, 2025Feb 28, 2025View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
97284,453Feb 26, 2025Feb 28, 2025View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
972972Feb 26, 2025Feb 28, 2025View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,1672,167May 21, 2024May 22, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,9172,917May 21, 2024May 22, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
2,16682,509May 15, 2024May 16, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
2,1660May 15, 2024May 16, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
97280,343Feb 26, 2024Feb 28, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
972972Feb 26, 2024Feb 28, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
97279,371Feb 26, 2024Feb 28, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
97278,399Feb 26, 2024Feb 28, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
9721,944Feb 26, 2024Feb 28, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
9720Feb 26, 2024Feb 28, 2024View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
19,000929,124May 16, 2023May 16, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
19,0000May 16, 2023May 16, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
26,00026,000May 15, 2023May 16, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,00035,000May 15, 2023May 16, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
5,833$1.15$6.7K910,124Mar 13, 2023Mar 13, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,6660Mar 11, 2023Mar 13, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,666915,957Mar 11, 2023Mar 13, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Feb 27, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,00035,000Feb 27, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,668$1.28$14.9K904,291Feb 27, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66723,333Feb 26, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667904,292Feb 26, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667915,959Feb 26, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66711,666Feb 26, 2023Feb 28, 2023View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,87511,875Aug 11, 2022Aug 11, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,875$2.66$31.6K892,625Aug 11, 2022Aug 11, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,875$2.16$25.6K904,500Aug 11, 2022Aug 11, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,00019,000May 16, 2022May 17, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
28,00028,000May 16, 2022May 17, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
9,000$1.95$17.6K892,625May 16, 2022May 17, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
18,0000May 13, 2022May 17, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
18,000901,625May 13, 2022May 17, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
4,083$3.20$13.1K883,625Mar 14, 2022Mar 14, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667887,708Mar 11, 2022Mar 14, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66711,666Mar 11, 2022Mar 14, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
4,083$3.33$13.6K876,041Mar 9, 2022Mar 9, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,6660Mar 8, 2022Mar 9, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,666880,124Mar 8, 2022Mar 9, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667868,458Feb 26, 2022Mar 1, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66723,333Feb 26, 2022Mar 1, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Feb 26, 2022Mar 1, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,00035,000Feb 26, 2022Mar 1, 2022View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
3,045$6.62$20.2K856,791May 17, 2021May 17, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
8,7000May 14, 2021May 17, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
8,700859,836May 14, 2021May 17, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,00018,000May 13, 2021May 17, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
27,00027,000May 13, 2021May 17, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
22,5000Apr 21, 2021Apr 21, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
22,500$2.40$54.0K877,719Apr 21, 2021Apr 21, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
22,500$8.57$192.8K855,219Apr 21, 2021Apr 21, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
4,083$8.54$34.9K851,136Apr 21, 2021Apr 21, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667855,219Mar 11, 2021Mar 12, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66723,333Mar 11, 2021Mar 12, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
3,500$9.60$33.6K843,552Mar 9, 2021Mar 9, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66711,666Mar 8, 2021Mar 9, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
3,500$9.18$32.1K835,385Mar 8, 2021Mar 9, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667847,052Mar 8, 2021Mar 9, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,6660Mar 5, 2021Mar 9, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,666838,885Mar 5, 2021Mar 9, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,00035,000Feb 26, 2021Feb 26, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Feb 26, 2021Feb 26, 2021View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
17,500$4.56$79.8K844,719Dec 15, 2020Dec 17, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
17,500$10.71$187.4K827,219Dec 15, 2020Dec 17, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
17,5000Dec 15, 2020Dec 17, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,7008,700May 14, 2020May 15, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,30013,300May 14, 2020May 15, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
2,404$11.84$28.5K827,219May 11, 2020May 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
8,0130May 8, 2020May 8, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
8,013829,623May 8, 2020May 8, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
3,500$11.14$39.0K821,610Mar 12, 2020Mar 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Mar 11, 2020Mar 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,00035,000Mar 11, 2020Mar 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
3,500$9.32$32.6K825,110Mar 10, 2020Mar 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,6660Mar 10, 2020Mar 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,666828,610Mar 10, 2020Mar 12, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
3,500$18.00$63.0K816,944Mar 9, 2020Mar 9, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667820,444Mar 8, 2020Mar 9, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66723,333Mar 8, 2020Mar 9, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
SALE
11,66711,666Mar 5, 2020Mar 9, 2020View →
INO
INOVIO PHARMACEUTICALS, INC.
PURCHASE
11,667808,777Mar 5, 2020Mar 9, 2020View →
Other insiders · INO
Loading peer insiders…
About this filer
CIK 0001669080
ROLE
Director
PRIMARY
INO
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001669080DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback